WPD Pharmaceuticals Granted Key Patent Exclusively Licensed From Wake Forest University
24 févr. 2020 03h05 HE
|
WPD Pharmaceuticals
VANCOUVER, British Columbia , Feb. 24, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical company, is pleased to...
WPD Pharmaceuticals' STAT3 Inhibitor Received FDA Approval of IND Status in Pediatric Brain Cancer Trial
20 févr. 2020 03h05 HE
|
WPD Pharmaceuticals
VANCOUVER, British Columbia, Feb. 20, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical company is pleased to provide...
WPD Pharmaceuticals’ WP1220 Drug Demonstrates Median Reduction of 56% in Skin Cancer Lesions in Clinical Trials
18 févr. 2020 07h35 HE
|
WPD Pharmaceuticals
VANCOUVER, British Columbia, Feb. 18, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical company, in collaboration...
Ankylosing Spondylitis Drugs Market To Reach USD 8.82 Billion By 2027 | Reports And Data
11 févr. 2020 16h00 HE
|
Reports and Data
New York, Feb. 11, 2020 (GLOBE NEWSWIRE) -- The global ankylosing spondylitis drugs market is forecast to reach USD 8.82 Billion by 2027, according to a new report by Reports and Data. Ankylosing...
WPD Pharmaceuticals’ WP1066 Drug Candidate Had Breakthrough Discovery
10 févr. 2020 03h05 HE
|
WPD Pharmaceuticals
VANCOUVER, British Columbia, Feb. 10, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical company, is pleased to...
WPD Pharmaceuticals’ Annamycin Drug Received FDA Approval of Fast Track Designation
05 févr. 2020 03h05 HE
|
WPD Pharmaceuticals
VANCOUVER, British Columbia, Feb. 05, 2020 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO) (FSE: 8SV1) (the “Company” or “WPD”), a clinical stage pharmaceutical company, is pleased to...
How Drug Dependence Impacts Decision Making - A Free Webinar from the Brain & Behavior Research Foundation
30 janv. 2020 09h00 HE
|
Brain & Behavior Research Foundation
New York, Jan. 30, 2020 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation is hosting a free webinar “How Drug Dependence Impacts Decision Making” on Tuesday, February 11, 2020, from...
Laguna Treatment Hospital’s New Online Calculator Offers a Personalized Estimate of How Long it Takes to Sober up from Different Drugs
06 janv. 2020 13h51 HE
|
American Addiction Centers, Inc.
ALISO VIEJO, Calif., Jan. 06, 2020 (GLOBE NEWSWIRE) -- This week, Laguna Treatment Hospital launched a drug effects calculator that estimates how long, after taking certain drugs, a person might...
Coverage Initiated for Trxade Group Inc. via NetworkNewsWire
23 avr. 2019 08h30 HE
|
Trxade Group Inc.
NEW YORK, April 23, 2019 (GLOBE NEWSWIRE) -- via NetworkWire - Trxade Group Inc. (OTCQB: TRXD), an integrated drug purchasing and delivery platform that enables trade among healthcare buyers and...
Provectus Biopharmaceuticals Announces Acceptances of PV-10 Poster Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting
17 avr. 2019 16h05 HE
|
Provectus Biopharmaceuticals Inc.
Metastatic neuroendocrine tumors; Advanced cutaneous melanomaIntratumoral administration of PV-10 to visceral and superficial disease locationsSingle-agent and combination therapy treatment settings ...